NTRA FY 2024 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

FY 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B+56.7% YoY

Gross Profit

$1.0B60.3% margin

Operating Income

-$222M-13.1% margin

Net Income

-$190M-11.2% margin

EPS (Diluted)

$-1.53

Cash Flow

Operating Cash Flow

$136M

Free Cash Flow

$69M

Stock-Based Comp.

$274M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$465M

Stockholders' Equity

$1.2B

Cash & Equivalents

$946M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.1B	+56.7%
Gross Profit	$1.0B	$493M	+107.6%
Operating Income	-$222M	-$446M	+50.2%
Net Income	-$190M	-$435M	+56.2%